Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | THRB | P10828 | 2/20 | 0.48 |
| ▸ | BLM | P54132 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.48 |
| ▸ | GABRP | O00591 | 1/20 | 0.48 |
| ▸ | GABRD | O14764 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.48 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.48 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.48 |
| ▸ | SLC6A1 | P30531 | 1/20 | 0.48 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11666501 | 1.00 | — | — | |
| SCHEMBL25747 | 0.97 | — | — | |
| SCHEMBL28382506 | 0.95 | CA2 (0.52) | LMNAKMT2ATHRBBLMNPSR1 | |
| SCHEMBL27732040 | 0.95 | — | — | |
| SCHEMBL20741410 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL1728565 | 0.95 | — | — | |
| Ammonia Solution, Strong SCHEMBL7610754 | 0.95 | — | — | |
| SCHEMBL5598893 | 0.95 | — | — | |
| SCHEMBL7466944 | 0.95 | — | — | |
| SCHEMBL510877 | 0.92 | CA2 (0.55) | LMNAKMT2ATHRBBLMNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108078828-A | A kind of baby's frost and its preparation process | 厦门嘉宝莱化妆品有限公司 | 2018-05-29 | — | — | CN | claimed |
| CN-103361149-A | Clutch release bearing lubricating assembly | SHANGHAI SHILU INFORMATION TECHNOLOGY CO LTD | 2013-10-23 | — | — | CN | claimed |
| CN-103205302-A | Novel formula of motor vehicle bearing butter with continuously descaling function | SHANGHAI SHILU INFORMATION TECHNOLOGY CO LTD | 2013-07-17 | — | — | CN | claimed |
| CN-110870849-A | Sulfamonomethoxine sodium injection and preparation method and preparation system thereof | 四川志邦生物科技有限公司 | 2020-03-10 | — | — | CN | disclosed |
| CN-106029050-B | Hair cosmetics composition and its application method | 朋友株式会社 | 2019-06-18 | — | — | CN | disclosed |
| CN-108078828-A | A kind of baby's frost and its preparation process | 厦门嘉宝莱化妆品有限公司 | 2018-05-29 | — | — | CN | disclosed |
| CN-108078828-A | A kind of baby's frost and its preparation process | 厦门嘉宝莱化妆品有限公司 | 2018-05-29 | — | — | CN | disclosed |
| CN-107669564-A | It is a kind of that there is reparative regeneration, replenishing water and preserving moisture, the skin care compositions of anti-aging | 江少卿 | 2018-02-09 | — | — | CN | disclosed |
| CN-104045771-B | Preparation method of homogeneous-phase synthesized betaine type amphoteric cellulose | 南京林业大学 | 2017-02-15 | — | — | CN | disclosed |
| CN-104164805-B | A method of enhancing papermaking wet-end paper strength by applying betaine amphoteric cellulose | 南京林业大学 | 2017-01-18 | — | — | CN | disclosed |
| CN-105816351-A | Cosmetic composition containing polyurethane dispersion | 科思创聚合物（中国）有限公司 | 2016-08-03 | — | — | CN | disclosed |
| CN-101227889-B | Cosmetics comprising a modified organopolysiloxane | DOW CORNING TORAY CO LTD | 2012-11-07 | — | — | CN | disclosed |
| US-8053592-B2 | Method for producing optically active α-ionone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-11-08 | — | — | US | disclosed |
| US-20110118500-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE a-IONONE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
| US-7902404-B2 | Method for producing optically active α-ionone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-03-08 | — | — | US | disclosed |
| US-20090216039-A1 | Method for Producing Optically Active Alpha-Ionone | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-08-27 | — | — | US | disclosed |
| US-7434586-B2 | Tobacco odor deodorizing perfume composition, tobacco odor deodorant, cigarette low in sidestream smoke odor, and tobacco package | JAPAN TOBACCO INC. (JP) | 2008-10-14 | — | — | US | disclosed |
| CN-101227889-A | Cosmetics comprising a modified organopolysiloxane | DOW CORNING TORAY CO LTD (JP) | 2008-07-23 | — | — | CN | disclosed |
| US-20060160719-A1 | Flavor and fragrance compositions | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-07-20 | — | — | US | disclosed |
| CN-1473010-A | Perfume compositions for deodorizing tobacco, tobacco deodorizing agents and cigarette and tobacco packages with little side smoke flow odor | �ձ��̲ݲ�ҵ��ʽ���� | 2004-02-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118500-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE a-IONONE | INF2, HSD17B1, AGL | LMNA 802/4885KMT2A 4638/4885THRB 2489/4885 |
| US-20060160719-A1 | Flavor and fragrance compositions | TAS2R8, TAS2R5, TAS2R7 | LMNA 3968/4885KMT2A 1609/4885THRB 2136/4885 |
| US-20090216039-A1 | Method for Producing Optically Active Alpha-Ionone | HSD17B1, ENO1, INF2 | LMNA 851/4885KMT2A 4695/4885THRB 1915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.